Glibenclamide therapy: pros and cons

The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2011
Materias:
Acceso en línea:https://doaj.org/article/176cc5d7a32949878807dfda4fd62a37
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:176cc5d7a32949878807dfda4fd62a37
record_format dspace
spelling oai:doaj.org-article:176cc5d7a32949878807dfda4fd62a372021-11-14T09:00:16ZGlibenclamide therapy: pros and cons2072-03512072-037810.14341/2072-0351-6231https://doaj.org/article/176cc5d7a32949878807dfda4fd62a372011-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6231https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibenclamide, but not other SU (gliclazide or glimepiride)Olga Konstantinovna VikulovaMarina Vladimirovna ShestakovaEndocrinology Research Centrearticlediabetes mellitus type 2glibenclamidehypoglysemiamortalityNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 14, Iss 3, Pp 92-96 (2011)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes mellitus type 2
glibenclamide
hypoglysemia
mortality
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes mellitus type 2
glibenclamide
hypoglysemia
mortality
Nutritional diseases. Deficiency diseases
RC620-627
Olga Konstantinovna Vikulova
Marina Vladimirovna Shestakova
Glibenclamide therapy: pros and cons
description The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibenclamide, but not other SU (gliclazide or glimepiride)
format article
author Olga Konstantinovna Vikulova
Marina Vladimirovna Shestakova
author_facet Olga Konstantinovna Vikulova
Marina Vladimirovna Shestakova
author_sort Olga Konstantinovna Vikulova
title Glibenclamide therapy: pros and cons
title_short Glibenclamide therapy: pros and cons
title_full Glibenclamide therapy: pros and cons
title_fullStr Glibenclamide therapy: pros and cons
title_full_unstemmed Glibenclamide therapy: pros and cons
title_sort glibenclamide therapy: pros and cons
publisher Endocrinology Research Centre
publishDate 2011
url https://doaj.org/article/176cc5d7a32949878807dfda4fd62a37
work_keys_str_mv AT olgakonstantinovnavikulova glibenclamidetherapyprosandcons
AT marinavladimirovnashestakova glibenclamidetherapyprosandcons
_version_ 1718429572579459072